Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
METDDED: Tadalafil and SGLT2 Inhibitors for Erectile Dysfunction in Metabolic Syndrome
NCT07563647Phase 4Completed
- Sponsor
- Kafrelsheikh University
- Start
- May 2025
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tadalafil in erectile dysfunction (ED), left ventricular diastolic dysfunction (LVDD), sponsored by Kafrelsheikh University. Started May 2025; status: completed.
02
Drugs
tadalafil
03
Conditions
erectile dysfunction (ED)left ventricular diastolic dysfunction (LVDD)
Beyond the preview
Go deeper on NCT07563647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07563647.